Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
作者信息
Zwaveling-Soonawala N, Hagebeuk E E, Slingerland A S, Ris-Stalpers C, Vulsma T, van Trotsenburg A S
出版信息
Diabetologia. 2011 Feb;54(2):469-71. doi: 10.1007/s00125-010-1981-8. Epub 2010 Nov 26.
Abstract
摘要
相似文献
1
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
Diabetologia. 2011 Feb;54(2):469-71. doi: 10.1007/s00125-010-1981-8. Epub 2010 Nov 26.
2
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
J Perinatol. 2012 Aug;32(8):645-7. doi: 10.1038/jp.2012.46.
3
ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.
4
An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Diabetes. 2007 Feb;56(2):328-36. doi: 10.2337/db06-1275.
5
Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
J Clin Endocrinol Metab. 2007 Apr;92(4):1276-82. doi: 10.1210/jc.2006-2490. Epub 2007 Jan 9.
6
Paediatric diabetes--which children can gain insulin independence?
Med J Aust. 2007 May 7;186(9):436-7. doi: 10.5694/j.1326-5377.2007.tb00991.x.
7
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
N Engl J Med. 2006 Aug 3;355(5):456-66. doi: 10.1056/NEJMoa055068.
8
Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
Curr Diab Rep. 2011 Dec;11(6):519-32. doi: 10.1007/s11892-011-0234-7.
9
Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.
Diabet Med. 2012 May;29(5):692-3. doi: 10.1111/j.1464-5491.2011.03487.x.
10
Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.
Diabetes Care. 2012 Feb;35(2):248-51. doi: 10.2337/dc11-1469. Epub 2011 Dec 30.
引用本文的文献
1
Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families.
Commun Med (Lond). 2025 Feb 22;5(1):47. doi: 10.1038/s43856-025-00750-9.
2
A synonymous variant leading to MODY13: A case report and literature review.
Mol Genet Metab Rep. 2023 Dec 26;38:101043. doi: 10.1016/j.ymgmr.2023.101043. eCollection 2024 Mar.
3
Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.
Front Endocrinol (Lausanne). 2021 Sep 9;12:727083. doi: 10.3389/fendo.2021.727083. eCollection 2021.
4
New insights into K channel gene mutations and neonatal diabetes mellitus.
Nat Rev Endocrinol. 2020 Jul;16(7):378-393. doi: 10.1038/s41574-020-0351-y. Epub 2020 May 6.
5
Recent Advances in Neonatal Diabetes.
Diabetes Metab Syndr Obes. 2020 Feb 12;13:355-364. doi: 10.2147/DMSO.S198932. eCollection 2020.
6
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective.
Diabetes Ther. 2016 Sep;7(3):591-600. doi: 10.1007/s13300-016-0192-9. Epub 2016 Aug 18.
7
Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents.
PLoS One. 2015 Jul 30;10(7):e0134476. doi: 10.1371/journal.pone.0134476. eCollection 2015.
8
Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment.
J Pediatr Endocrinol Metab. 2015 Nov 1;28(11-12):1279-86. doi: 10.1515/jpem-2015-0170.
9
Neonatal diabetes with intractable epilepsy: DEND syndrome.
Indian J Pediatr. 2014 Dec;81(12):1387-8. doi: 10.1007/s12098-014-1486-4. Epub 2014 Jun 10.
10
Neonatal diabetes caused by activating mutations in the sulphonylurea receptor.
Diabetes Metab J. 2013 Jun;37(3):157-64. doi: 10.4093/dmj.2013.37.3.157.
本文引用的文献
1
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
Diabet Med. 2008 Mar;25(3):277-81. doi: 10.1111/j.1464-5491.2007.02373.x.
2
Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
Diabetes Care. 2008 Feb;31(2):204-9. doi: 10.2337/dc07-1785. Epub 2007 Nov 19.
3
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Neurology. 2007 Sep 25;69(13):1342-9. doi: 10.1212/01.wnl.0000268488.51776.53. Epub 2007 Jul 25.
4
Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
Diabetologia. 2006 Nov;49(11):2559-63. doi: 10.1007/s00125-006-0407-0. Epub 2006 Sep 19.
5
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
N Engl J Med. 2006 Aug 3;355(5):467-77. doi: 10.1056/NEJMoa061759.
6
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
N Engl J Med. 2006 Aug 3;355(5):456-66. doi: 10.1056/NEJMoa055068.
7
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Hum Mol Genet. 2006 Jun 1;15(11):1793-800. doi: 10.1093/hmg/ddl101. Epub 2006 Apr 13.
8
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
N Engl J Med. 2004 Apr 29;350(18):1838-49. doi: 10.1056/NEJMoa032922.
9
Transmembrane topology of the sulfonylurea receptor SUR1.
J Biol Chem. 2001 Nov 2;276(44):41270-8. doi: 10.1074/jbc.M106555200. Epub 2001 Aug 23.
Zotero 插件